期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed? 被引量:2
1
作者 dong yun kim Jun Yong Park 《Hepatobiliary Surgery and Nutrition》 SCIE 2019年第5期522-524,共3页
Non-alcoholic fatty liver disease(NAFLD)comprisesisolated hepatic steatosis,non-alcoholic steatohepatitis(NASH),liver failure-associated complications of livercirrhosis,and liver cancer.These are forecasted to be thel... Non-alcoholic fatty liver disease(NAFLD)comprisesisolated hepatic steatosis,non-alcoholic steatohepatitis(NASH),liver failure-associated complications of livercirrhosis,and liver cancer.These are forecasted to be theleading liver diseases in the future. 展开更多
关键词 LIVER NAFLD DRUG
原文传递
Genetic risk factors associated with NAFLD 被引量:1
2
作者 dong yun kim Jun Yong Park 《Hepatoma Research》 2020年第12期42-51,共10页
Non-alcoholic fatty liver disease(NAFLD)is estimated to affect 25%of the worldwide population,and is the leading cause of chronic liver disease in developed countries.Genetic research on NAFLD has included heritabilit... Non-alcoholic fatty liver disease(NAFLD)is estimated to affect 25%of the worldwide population,and is the leading cause of chronic liver disease in developed countries.Genetic research on NAFLD has included heritability studies,candidate gene studies,familial aggregation studies,and genome-wide association studies(GWAS).Next-generation sequencing approaches,such as whole-genome sequencing and whole-exon sequencing,are emerging as the post-GWAS era of genetic research.However,GWAS remains more practical for elucidating the genetic factors related to NAFLD,which is affected by thousands of common genetic variants and does not follow Mendelian inheritance.In the present review,we summarize the current knowledge regarding five GWAS-identified genetic loci that are associated with NAFLD.We also discuss the relationships between NAFLD-predisposing polymorphisms and cardiovascular disease,and potential applications for these identified genetic loci. 展开更多
关键词 Genome-wide association study non-alcoholic fatty liver disease PNPLA3 TM6SF2 GCKR MBOAT7 HSD17B13
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部